Skip to content

A study to evaluate the efficacy of Test Product in reducing appearance of wrinkles, expression lines and dark spots.

A clinical study to evaluate cosmetic efficacy and safety of an antioxidant serum in reducing appearance of wrinkles, expression lines and dark spots in healthy adult participants. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/090488
Enrollment
24
Registered
2025-07-08
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Serum: Sufficient quantity of serum will be applied on entire face, gently massaged till the serum gets completely absorbed. Twice daily application for 2 months Control Intervention1:

Sponsors

KAYURA EFFECT LLP
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Healthy adult males and non-pregnant/non-lactating females with age 30 to 55 years (both inclusive at the time of consent). 2. Participants having fine line/wrinkles score of 1 (Occasional number of fine lines widely spaced) or 2 (Few number of discreet fine lines) as per Physician Global Assessment (PGA). 3. Participants with at least 2 dark spots on the face. 4. Participants with uneven skin tone and with dull skin. 5. Participants having good general health as determined by the Investigator on the basis of medical history. 6. Participants of childbearing potential must have a negative urine pregnancy test performed at screening/enrollment visit.

Exclusion criteria

Exclusion criteria: 1. Participants having any active dermatological skin conditions (e.g., acne, eczema, psoriasis, rosacea etc.), that might interfere with clinical assessments. 2. Participants having excessive hair, moles, open wounds, cuts, abrasions, irritation symptoms, tattoos, scars, sunburn or any dermatological condition on the test site(s) that can interfere with the reading. 3. Participants who are receiving topical or systemic treatments for fine line/wrinkles and pigmentation. 4. Participants are unwilling to avoid unprotected sun or other UV radiation exposure during the study period. 5. Chronic illness which may influence the cutaneous state. 6. Participants with known allergy or sensitivity to cosmetic products and/or any ingredients of the test product. 7. Participants having a history of diabetes, acute cardiac and circulatory diseases, HIV, hepatitis. 8. Participants with history of drug and alcohol abuse. 9. Any other condition which could warrant exclusion from the study, as per the Dermatologist s/investigator s discretion.

Design outcomes

Primary

MeasureTime frame
Dermatological assessment of fine line/wrinkles and coarse wrinkling/linesTimepoint: Day 00, Day 15, Day 30, Day 45 and Day 60

Secondary

MeasureTime frame
Dermatological assessment of skin tone evennessTimepoint: Day 00, Day 15, Day 30, Day 45 and Day 60;Instrumental assessment of skin lightening, skin gloss/radiance, fine lines/wrinkles, dark spots and skin textureTimepoint: Day 00, Day 15, Day 30, Day 45 and Day 60;Participant Satisfaction QuestionnaireTimepoint: Day 15, Day 30, Day 45 and Day 60

Countries

India

Contacts

Public ContactDr Parth Joshi

Cliantha Research

ssethi@cliantha.com9825784942

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026